To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
USA119th CongressHR-8630| House
| Updated: 4/30/2026
Michael A. Rulli
Republican Representative
Ohio
Cosponsors (1)
Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
USA119th CongressHR-8630| House
| Updated: 4/30/2026
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Michael A. Rulli
Republican Representative
Ohio
Cosponsors (1)
Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted